NCT04727970View on ClinicalTrials.gov

Tricaprilin Infantile Spasms Pilot Study

PHASE1CompletedINTERVENTIONAL
Enrollment

8

Participants

Timeline

Start Date

November 1, 2021

Primary Completion Date

December 4, 2023

Study Completion Date

December 4, 2023

Conditions
Infantile Spasm
Interventions
DRUG

Tricaprilin

Tricaprilin will be emulsified in infant formula/milk

Trial Locations (4)

2031

Sydney Children's Hospital, Randwick

3052

Royal Children's Hospital Melbourne, Parkville

4101

Queensland Children's Hospital, South Brisbane

229899

KK Women's and Children's Hospital, Singapore

Sponsors

Lead Sponsor

Cerecin
All Listed Sponsors
lead

Cerecin

INDUSTRY

NCT04727970 - Tricaprilin Infantile Spasms Pilot Study | Biotech Hunter | Biotech Hunter